Ulrich Herrlinger

7PUBLICATIONS
25CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 04, 2026
Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial.

|Apr 08, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

Frank A Giordano, Julian P Layer, Roberta Turiello

|Dec 16, 2024
Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition.

Elena N C Schmidt, Bernd O Evert, Barbara E F Pregler

|Jun 20, 2024
Current status of precision oncology in adult glioblastoma.

Johannes Weller, Anna-Laura Potthoff, Thomas Zeyen

|May 28, 2024
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.

Frank A Giordano, Julian P Layer, Sonia Leonardelli

|Apr 03, 2024
The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours.

Matthias Schneider, Anna-Laura Potthoff, Georg Karpel-Massler

Pageof 2

Frequent Collaborators

4 joint publications

Matthias Schneider

3 joint publications

Anna-Laura Potthoff

3 joint publications

Michael Platten

2 joint publications

Clemens Seidel